Antenatal Corticosteroid in Twin-Pregnant Women at Risk of Late Preterm Delivery
JAMA Pediatrics · 01.12.2025 · 179 (12) · 1275
DOI: 10.1001/jamapediatrics.2025.3284 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA Pediatrics, erschienen am 01.12.2025. Verfasst von Seung Mi Lee und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Betamethasone, Glucocorticoids, Pregnancy, Twin, Premature Birth. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Recent guidelines have recommended corticosteroid injection in women with singleton pregnancies at risk of late preterm delivery. However, the effectiveness of antenatal corticosteroid administration in women with twin pregnancies at risk of late preterm delivery has not been evaluated, and studies on this population are lacking.
Objective
To evaluate whether antenatal betamethasone administration reduces the risk of neonatal respiratory morbidity in late preterm twin neonates. Design, Setting, and Participants In this multicenter randomized trial, twin-pregnant women at 34 weeks 0 days to 36 weeks 5 days of gestation at risk of late preterm delivery were enrolled across 8 university-based clinical centers in Korea. Data were collected between May 2018 and July 2024. Intention-to-treat analysis was performed.
Intervention
The participants received 2 injections of betamethasone or placebo after randomization (1:1). Main Outcomes and Measures The primary outcome was perinatal death within 72 hours after birth or severe neonatal respiratory morbidity. The exploratory outcomes were mild neonatal respiratory morbidities, other neonatal respiratory morbidities, other neonatal complications, or maternal complications.
Results
A total of 812 participants were randomized and analyzed, with 410 in the intervention group (median [IQR] age, 35 [33-37] years) and 402 in the placebo group (median [IQR] age, 35 [32-38] years). Among 1620 neonates (818 in the intervention group and 802 in the placebo group), there were no perinatal deaths in either group, and severe neonatal respiratory morbidity occurred in 99 neonates (6.1%), with lower risk in the betamethasone group than in the placebo group (39 [4.8%] vs 60 [7.5%]; relative risk [RR], 0.64 [95% CI, 0.42-0.98]). For the exploratory outcomes, continuous positive airway pressure use for 2 hours or more (RR, 0.58 [95% CI, 0.35-0.95]) and transient tachypnea of the newborn (RR, 0.47 [95% CI, 0.25-0.89]) were lower in the betamethasone group. The risk of primary outcome and mild respiratory morbidities was reduced only in neonates delivered between 12 hours or more and less than 7 days after the first betamethasone administration. The risk of neonatal hypoglycemia was increased in the betamethasone group (128 [15.6%] vs 94 [11.7%]; RR, 1.33 [95% CI, 1.01-1.75]), but the risk of neonatal sepsis or maternal chorioamnionitis did not differ between the 2 groups. Conclusions and Relevance In this randomized clinical trial, antenatal betamethasone administration in women with twin pregnancies at risk of late preterm delivery significantly reduced the risk of neonatal respiratory morbidity. The outcomes from this study could serve as a valuable reference in clinical management of twin pregnancies at risk of late preterm delivery. Trial Registration ClinicalTrials.gov Identifier: NCT03547791
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
- Department of Obstetrics and Gynecology & Healthcare AI Research Institute, Seoul National University Hospital, Seoul, Korea.
- Medical Big Data Research Center & Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University, Seoul, Korea.
- Interdisciplinary Program in Artificial Intelligence, Seoul National University, Seoul, Korea.
- Department of Obstetrics and Gynecology, Dongguk University Ilsan Hospital, Goyang, Korea.
- Family Medicine Residency, Providence St Joseph Eureka Hospital, Eureka, California.
Zitieren
APA
Lee, S. M., Park, H. S., Choi, S. R., Lee, J., Kim, H. J., Park, J. Y., Oh, K. J., Cho, G. J., Oh, M. J., Chung, J. H., Kim, S. M., Kim, B. J., Kim, S. Y., Hong, S., Jung, Y. M., Lee, S. J., Seong, J. S., Kim, H., Oh, S., …, & Jun, J. K. (2025). Antenatal Corticosteroid in Twin-Pregnant Women at Risk of Late Preterm Delivery. JAMA Pediatrics, 179(12), 1275. https://doi.org/10.1001/jamapediatrics.2025.3284
Vancouver
Lee SM, Park HS, Choi SR, Lee J, Kim HJ, Park JY, et al. Antenatal Corticosteroid in Twin-Pregnant Women at Risk of Late Preterm Delivery. JAMA Pediatrics. 2025;179(12):1275. doi:10.1001/jamapediatrics.2025.3284
BibTeX
@article{Lee2025,
author = {Lee, Seung Mi and Park, Hyun Soo and Choi, Soo Ran and Lee, Jeesun and Kim, Hyeon Ji and Park, Jee Yoon and Oh, Kyung Joon and Cho, Geum Joon and Oh, Min-Jeong and Chung, Jin Hoon and Kim, Sun Min and Kim, Byoung Jae and Kim, Suk Young and Hong, Subeen and Jung, Young Mi and Lee, Se Jin and Seong, Ji Su and Kim, Haemin and Oh, Sohee and Lee, Joongyub and Jin, Young Rang and Kim, Ji Hoi and Cho, Hee Young and Park, Chan-Wook and Park, Joong Shin and Jun, Jong Kwan},
title = {Antenatal Corticosteroid in Twin-Pregnant Women at Risk of Late Preterm Delivery},
journal = {JAMA Pediatrics},
year = {2025},
volume = {179},
number = {12},
pages = {1275},
doi = {10.1001/jamapediatrics.2025.3284}
}
EUVIMED